These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14623802)

  • 1. Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness.
    Welzig CM; Shin DG; Park HJ; Kim YJ; Saul JP; Galper JB
    Circulation; 2003 Dec; 108(22):2743-6. PubMed ID: 14623802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of statins (pravastatin or simvastatin) on ventricular ectopic complexes: Galpha(i2), a possible molecular marker for ventricular irritability.
    Welzig CM; Park HJ; Naggar J; Confalone D; Rhofiry J; Shea J; Karas RH; Estes NA; Galper JB
    Am J Cardiol; 2010 Apr; 105(8):1112-7. PubMed ID: 20381662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta regulates the expression of G alpha(i2) via an effect on the localization of ras.
    Ward SM; Gadbut AP; Tang D; Papageorge AG; Wu L; Li G; Barnett JV; Galper JB
    J Mol Cell Cardiol; 2002 Sep; 34(9):1217-26. PubMed ID: 12392895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sterol regulatory element binding proteins in the regulation of Galpha(i2) expression in cultured atrial cells.
    Park HJ; Begley U; Kong D; Yu H; Yin L; Hillgartner FB; Osborne TF; Galper JB
    Circ Res; 2002 Jul; 91(1):32-7. PubMed ID: 12114319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
    Vivekananthan K; Mehra MR; Uber PA; DeGruiter H; Lavie CJ; Milani RV
    J Assoc Physicians India; 2002 May; 50(5):682-4. PubMed ID: 12186124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and colocalization of G protein alpha subunits and Purkinje cell protein 2 (Pcp2) in mammalian cerebellum.
    Redd KJ; Oberdick J; McCoy J; Denker BM; Luo Y
    J Neurosci Res; 2002 Dec; 70(5):631-7. PubMed ID: 12424730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide and cardiac parasympathetic control in human heart failure.
    Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
    Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
    Deedwania PC; Hunninghake DB; Bays HE; Jones PH; Cain VA; Blasetto JW;
    Am J Cardiol; 2005 Feb; 95(3):360-6. PubMed ID: 15670545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics.
    Zuberi Z; Birnbaumer L; Tinker A
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1822-30. PubMed ID: 18832081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 11 treatment alters the protein content of Galpha(i2) and adipogenic transcription factors in 3T3-L1 adipocytes.
    Tenney R; Pekala PH
    Cytokine; 2004 Jul; 27(1):1-6. PubMed ID: 15207245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.
    Rau T; Nose M; Remmers U; Weil J; Weissmüller A; Davia K; Harding S; Peppel K; Koch WJ; Eschenhagen T
    FASEB J; 2003 Mar; 17(3):523-5. PubMed ID: 12631586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
    Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
    Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of clinical epidemiology and intervention trial of hyperlipidemia in Japan].
    Itakura H
    Nihon Rinsho; 2002 May; 60(5):889-98. PubMed ID: 12029990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.